These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12690168)

  • 1. American Chemical Society meeting. Tiny transistors scout for cancer.
    Service RF
    Science; 2003 Apr; 300(5617):242-3. PubMed ID: 12690168
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of sensitivity and specificity by surface modification of carbon nanotubes in diagnosis of prostate cancer based on carbon nanotube field effect transistors.
    Kim JP; Lee BY; Lee J; Hong S; Sim SJ
    Biosens Bioelectron; 2009 Jul; 24(11):3372-8. PubMed ID: 19481922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Materials science. Tiny particles flag scarce proteins.
    Service RF
    Science; 2003 Sep; 301(5641):1827. PubMed ID: 14512591
    [No Abstract]   [Full Text] [Related]  

  • 4. Microchip-based multiplex electro-immunosensing system for the detection of cancer biomarkers.
    Ko YJ; Maeng JH; Ahn Y; Hwang SY; Cho NG; Lee SH
    Electrophoresis; 2008 Aug; 29(16):3466-76. PubMed ID: 18651704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using predictive value, sensitivity and specificity to interpret laboratory tests: PSA for the diagnosis of prostate cancer.
    Ashley T
    J Insur Med; 2005; 37(4):261-3. PubMed ID: 16459948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosensors: filling the gap.
    Therriault D
    Nat Nanotechnol; 2007 Jul; 2(7):393-4. PubMed ID: 18654319
    [No Abstract]   [Full Text] [Related]  

  • 7. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
    Wan XS; Xu YA; Ware JH; Kennedy AR
    Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer].
    Medvedev VL
    Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carcinoembryonic antigen in the diagnostic approach and monitoring of patients with colorectal carcinoma].
    Stefanović L; Prvulović M; Kamenjicki E; Selir Z; Muzikravić L; Sterio B; Sljapić N
    Med Pregl; 1988; 41(3-4):101-3. PubMed ID: 3054459
    [No Abstract]   [Full Text] [Related]  

  • 10. In-situ quantitative analysis of a prostate-specific antigen (PSA) using a nanomechanical PZT cantilever.
    Hwang KS; Lee JH; Park J; Yoon DS; Park JH; Kim TS
    Lab Chip; 2004 Dec; 4(6):547-52. PubMed ID: 15570363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer.
    Harris M
    Aust Fam Physician; 2003 Jun; 32(6):395. PubMed ID: 12833759
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogold labeling-induced synergy effect for amplified photoelectrochemical immunoassay of prostate-specific antigen.
    Zhao WW; Dong XY; Wang J; Kong FY; Xu JJ; Chen HY
    Chem Commun (Camb); 2012 May; 48(43):5253-5. PubMed ID: 22362020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosensor developments: application to prostate-specific antigen detection.
    Healy DA; Hayes CJ; Leonard P; McKenna L; O'Kennedy R
    Trends Biotechnol; 2007 Mar; 25(3):125-31. PubMed ID: 17257699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of free prostate specific antigen (fPSA) on a nanoporous gold platform.
    Shulga OV; Zhou D; Demchenko AV; Stine KJ
    Analyst; 2008 Mar; 133(3):319-22. PubMed ID: 18299744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary view of prostate cancer diagnosis and treatment.
    Costello AJ
    Aust Fam Physician; 2003 Jun; 32(6):396-8. PubMed ID: 12833761
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of tumor markers using single-walled carbon nanotube field effect transistors.
    Park DW; Kim YH; Kim BS; So HM; Won K; Lee JO; Kong KJ; Chang H
    J Nanosci Nanotechnol; 2006 Nov; 6(11):3499-502. PubMed ID: 17252798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative histological and cytological, autoradiographic and immuno-histochemical studies of prostatic carcinomas].
    Vogel J; Helpap B
    Verh Dtsch Ges Pathol; 1986; 70():332-8. PubMed ID: 2435082
    [No Abstract]   [Full Text] [Related]  

  • 18. Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection.
    Kline EE; Treat EG; Averna TA; Davis MS; Smith AY; Sillerud LO
    J Urol; 2006 Nov; 176(5):2274-9. PubMed ID: 17070311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on screening for prostate cancer with prostate-specific antigen.
    Schmid HP; Riesen W; Prikler L
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoassay of prostate-specific antigen (PSA) using resonant frequency shift of piezoelectric nanomechanical microcantilever.
    Lee JH; Hwang KS; Park J; Yoon KH; Yoon DS; Kim TS
    Biosens Bioelectron; 2005 Apr; 20(10):2157-62. PubMed ID: 15741091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.